These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 17161587

  • 1. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G.
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [Abstract] [Full Text] [Related]

  • 2. Use of levetiracetam in hospitalized patients.
    Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [Abstract] [Full Text] [Related]

  • 3. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S, Grumbt M, Müller M, Schulze A.
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [Abstract] [Full Text] [Related]

  • 4. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 5. Levetiracetam in children with refractory status epilepticus.
    Gallentine WB, Hunnicutt AS, Husain AM.
    Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
    [Abstract] [Full Text] [Related]

  • 6. Nonconvulsive status epilepticus on treatment with levetiracetam.
    Atefy R, Tettenborn B.
    Epilepsy Behav; 2005 Jun; 6(4):613-6. PubMed ID: 15876554
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C, Rubio G.
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [Abstract] [Full Text] [Related]

  • 8. Intravenous levetiracetam for epileptic seizure emergencies in older people.
    Beyenburg S, Reuber M, Maraite N.
    Gerontology; 2009 Aug; 55(1):27-31. PubMed ID: 18953167
    [Abstract] [Full Text] [Related]

  • 9. Levetiractam in the treatment of two children with myoclonic status epilepticus.
    Haberlandt E, Sigl SB, Scholl-Buergi S, Karall D, Rauchenzauner M, Rostásy K.
    Eur J Paediatr Neurol; 2009 Nov; 13(6):546-9. PubMed ID: 19010072
    [Abstract] [Full Text] [Related]

  • 10. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
    Gibbs JE, Walker MC, Cock HR.
    Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
    [Abstract] [Full Text] [Related]

  • 11. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M.
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [Abstract] [Full Text] [Related]

  • 12. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 13. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA, Edelbroek PM, Gorter JA.
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS, Benatar M.
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [Abstract] [Full Text] [Related]

  • 15. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
    Atmaca MM, Orhan EK, Bebek N, Gurses C.
    Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
    [Abstract] [Full Text] [Related]

  • 16. Determinants of success in the use of oral levetiracetam in status epilepticus.
    Rossetti AO, Bromfield EB.
    Epilepsy Behav; 2006 May; 8(3):651-4. PubMed ID: 16495155
    [Abstract] [Full Text] [Related]

  • 17. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A, Gelisse P, Genton P.
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [Abstract] [Full Text] [Related]

  • 18. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
    Trabacca A, Profice P, Costanza MC, Gesualdi M, De Rinaldis M.
    J Child Neurol; 2007 May; 22(5):639-41. PubMed ID: 17690075
    [Abstract] [Full Text] [Related]

  • 19. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S, Muroi C, Seule M, Bjeljac M, Keller E.
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [Abstract] [Full Text] [Related]

  • 20. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF, Crisp ED, Kayani S, Rajab H.
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.